🇺🇸 Allisartan Isoproxil in United States

14 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 14

Most-reported reactions

1. Cerebral Infarction — 2 reports (14.29%)
2. Drug-Induced Liver Injury — 2 reports (14.29%)
3. Hypotension — 2 reports (14.29%)
4. Renal Impairment — 2 reports (14.29%)
5. Abdominal Distension — 1 report (7.14%)
6. Angina Pectoris — 1 report (7.14%)
7. Anion Gap Increased — 1 report (7.14%)
8. Arrhythmia — 1 report (7.14%)
9. Arterial Stenosis — 1 report (7.14%)
10. Atrial Fibrillation — 1 report (7.14%)

Source database →

Frequently asked questions

Is Allisartan Isoproxil approved in United States?

Allisartan Isoproxil does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Allisartan Isoproxil in United States?

Guangdong Provincial People's Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.